Trial intelligence / Profile preview

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis

NCT00630838Phase 2Completed

Sponsor
University of Michigan
Start
Sep 2006
Primary completion
Sep 2010
Modality
Multi-strain Products
Countries
1
01

Overview

A Phase 2 trial of VSL#3 in enterocolitis, sponsored by University of Michigan. Started Sep 2006; status: completed.

02

Drugs

VSL#3
03

Conditions

enterocolitis

Beyond the preview

Go deeper on NCT00630838.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00630838.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call